Companies: 10,795·Total market cap: $144.5T
Evolent Health, Inc.

Evolent Health, Inc.

EVHNYSEHealthcare● Active
$4.66
+$0.44(+10.43%)
Market Cap$524161772
P/E Ratio—
52W High$12.065
52W Low$2.095
Cash on HandFinancialsRevenue

Evolent Health, Inc. (EVH) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

EVH · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$151.9M▼ -7.1% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$151.9M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
-7.1%
vs prior fiscal year
Latest Quarter
$166.0M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$151.9MCash on Hand
Total Debt$989.7MTotal Debt
Net Cash / Net Debt−$837.8MNet Debt Position
Cash vs Debt Ratio
Cash 13%Debt 87%

Evolent Health, Inc. carries a net debt position of $837.8M. Total debt ($989.7M) exceeds cash on hand ($151.9M). Evolent Health, Inc. cash vs debt ratio: 13% cash / 87% debt.

Net Cash = Cash & ST Investments − Total Debt$151.9M − $989.7M = −$837.8M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
EVH annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$151.9M-7.1%
Dec 31, 2024$163.5M-15.2%
Dec 31, 2023$192.8M+2.5%
Dec 31, 2022$188.2M-29.3%
Dec 31, 2021$266.3M-20.1%
EVH cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Evolent Health, Inc.
Evolent Health, Inc.YOU
EVH
$151.9M29.0%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Evolent Health, Inc. (EVH) cash on hand as of December 31, 2025 is $151.9M, comprising $151.9M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Evolent Health, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Evolent Health, Inc. cash reserves or cash position.

Evolent Health, Inc. annual cash on hand history shows decreased -7.1% in 2025: decreased -7.1% in 2025. Evolent Health, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Evolent Health, Inc. carries total debt of $989.7M against cash of $151.9M, resulting in a net debt position of -$837.8M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

EVH cash on hand · 5 questions

As of December 31, 2025, Evolent Health, Inc. (EVH) has $151,856,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $151,856,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $166,005,000. Data sourced from the annual 10-K filing via FMP.

EVH cash on handEVH cash reservesEVH cash 2025how much cash does EVH have

▸ Source: FMP /balance-sheet-statement · US GAAP · Evolent Health, Inc. · Evolent Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025